Quantcast
Channel: cafepharma - chronic kidney disease
Browsing all 27 articles
Browse latest View live

Keryx's First Step Toward Zerenex Approval

Keryx's First Step Toward Zerenex Approval Motley Fool

View Article



3 Things You Need to Know from Keryx's Stifel Conference Presentation

3 Things You Need to Know from Keryx's Stifel Conference Presentation Motley Fool

View Article

Keryx's kidney drug meets main goals of mid-stage study

Keryx's kidney drug meets main goals of mid-stage study Yahoo/Reuters

View Article

3 Bold Predictions for Keryx Biopharmaceuticals in 2014

3 Bold Predictions for Keryx Biopharmaceuticals in 2014 Motley Fool

View Article

La Jolla Pharma's drug improves kidney function in mid-stage study

La Jolla Pharma's drug improves kidney function in mid-stage study Yahoo/Reuters

View Article


Impax to Sell Authorized Generic Renvela

Impax to Sell Authorized Generic Renvela Yahoo/Zacks.com

View Article

Amgen thyroid drug succeeds in late stage kidney patient trial

Amgen thyroid drug succeeds in late stage kidney patient trial Yahoo/Reuters

View Article
Browsing all 27 articles
Browse latest View live




Latest Images